VIRGINIA GILL: Open Payments
NPI 1558097444 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,982 in 80 payments from 26 companies in 2025. Trend: 2023 $145 · 2024 $1,882 · 2025 $1,982
Food & beverage: $1,982
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $230 |
| Eisai Inc. | 3 | $210 |
| Lilly USA, LLC | 7 | $209 |
| ANI Pharmaceuticals, Inc. | 9 | $170 |
| ABBVIE INC. | 10 | $141 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| ACADIA Pharmaceuticals Inc | 6 | $124 |
| ARGENX US, INC. | 5 | $112 |
| Biogen, Inc. | 4 | $102 |
| Mallinckrodt Hospital Products Inc. | 3 | $77 |
Products named: Leqembi, KISUNLA, PURIFIED CORTROPHIN GEL, JARDIANCE, NUPLAZID, ZAVZPRET, VYVGART HYTRULO, UBRELVY.
Industry payments across MS — which companies pay providers there.
